1Samuel D, Feray C, Bismuth H. Hepatitis viruses and liver transplantation. J Gastroenterol Hepatol, 1997, 12(9-10): S335-S341.
2Herrero JI, Quiroga J, Sangro B, et al. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation. Dig Dis Sci, 1998, 43(6) : 1186-1189.
4Samuel D, Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.lancet, 1991, 337(8745): 813-815.
5Sawyer RG, McGory RW, Gaffey MJ, et al. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg, 1998, 227(6) :841-850.
6Jurim O, Martin P, Winston DJ, et al. Failure of ganciclovir prophylaxis to prevent allograft reinfection following orthotopic liver transplantation for chronic hepatitis B infection. Liver Transpl Surg, 1996, 2(5): 370-374.
7Shouval D, Sanuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a conelse review. Hepatology, 2000, 32(6): 1189-1195.
8Mutimer D, Pillay D, Shields P, et al. Outcome of lamivudine resistance hepatitis B virus infection in the liver transplant recipient.Gut, 2000, 46(1): 107-113.
9Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatolngy,1998, 28(2): 585-589.
10Dodson SF, de Vera ME, Bonham CA, et al. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl, 2000, 6: 434-439.
